Email Alert | RSS

Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (6): 613-619.doi: 10.19982/j.issn.1000-6621.20220521

• Review Articles • Previous Articles     Next Articles

Research progress on long non-coding RNA’s anti infection function against Mycobacterium tuberculosis

Dong Jing, Shi Yuting, Pan Liping(), Zhang Zongde()   

  1. Beijing Chest Hospital,Capital Medical University/Beijing Key Laboratory of Drug Resistant Tuberculosis/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149,China
  • Received:2023-01-10 Online:2023-06-10 Published:2023-06-06
  • Contact: Pan Liping,E-mail:panliping2006@163.com;Zhang Zongde,E-mail:zzd417@163.com
  • Supported by:
    National Natural Science Foundation of China(82172279);National Natural Science Foundation of China(81902024);Tongzhou District Science and Technology Plan Project(KJ2022CX042);Tongzhou District Canal Plan Talent Project(YH201807);Tongzhou District Canal Plan Talent Project(YH202001)

Abstract:

The pathogenesis and immunological mechanism of Mycobacterium tuberculosis (MTB) infection and further development of active tuberculosis have not yet been fully elucidated. Recently, long non-coding RNA (lncRNA) has received more attention in MTB infection and active tuberculosis development study, for it is involved in a variety of biological processes, such as gene expression regulation, cell cycle regulation, cell differentiation, and so on. It is of great significance to illustrate the regulation mechanism of aberrant lncRNA in the developing and progression of tuberculosis, which could help us further understand the mechanism of host immunological response to MTB infection and progression. Therefore, we reviewed the research progress of impact and specific mechanisms of lncRNA affecting human immunological response to MTB infection, to facilitate future development of novel lncRNA-based immunotherapy of tuberculosis.

Key words: Mycobacterium tuberculosis, Infection, Immunity, RNA

CLC Number: